Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies.
Identifieur interne : 002788 ( PubMed/Corpus ); précédent : 002787; suivant : 002789Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies.
Auteurs : Caren J. Stark ; C D AtreyaSource :
- Virology journal [ 1743-422X ] ; 2005.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : Viral Vaccines.
- chemical , therapeutic use : Antiviral Agents.
- drug therapy : Severe Acute Respiratory Syndrome.
- genetics : SARS Virus.
- physiology : SARS Virus.
- prevention & control : Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome.
Abstract
In the aftermath of the SARS epidemic, there has been significant progress in understanding the molecular and cell biology of SARS-CoV. Some of the milestones are the availability of viral genome sequence, identification of the viral receptor, development of an infectious cDNA clone, and the identification of viral antigens that elicit neutralizing antibodies. However, there is still a large gap in our understanding of how SARS-CoV interacts with the host cell and the rapidly changing viral genome adds another variable to this equation. Now the SARS-CoV story has entered a new phase, a search for preventive strategies and a cure for the disease. This review highlights the progress made in identifying molecular aspects of SARS-CoV biology that is relevant in developing disease prevention strategies. Authors conclude that development of successful SARS-CoV vaccines and antivirals depends on the progress we make in these areas in the immediate future.
DOI: 10.1186/1743-422X-2-35
PubMed: 15833113
Links to Exploration step
pubmed:15833113Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies.</title><author><name sortKey="Stark, Caren J" sort="Stark, Caren J" uniqKey="Stark C" first="Caren J" last="Stark">Caren J. Stark</name><affiliation><nlm:affiliation>Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, MD 20892, USA. starkc@cber.fda.gov</nlm:affiliation></affiliation></author><author><name sortKey="Atreya, C D" sort="Atreya, C D" uniqKey="Atreya C" first="C D" last="Atreya">C D Atreya</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15833113</idno><idno type="pmid">15833113</idno><idno type="doi">10.1186/1743-422X-2-35</idno><idno type="wicri:Area/PubMed/Corpus">002788</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002788</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies.</title><author><name sortKey="Stark, Caren J" sort="Stark, Caren J" uniqKey="Stark C" first="Caren J" last="Stark">Caren J. Stark</name><affiliation><nlm:affiliation>Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, MD 20892, USA. starkc@cber.fda.gov</nlm:affiliation></affiliation></author><author><name sortKey="Atreya, C D" sort="Atreya, C D" uniqKey="Atreya C" first="C D" last="Atreya">C D Atreya</name></author></analytic><series><title level="j">Virology journal</title><idno type="eISSN">1743-422X</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term><term>SARS Virus (genetics)</term><term>SARS Virus (physiology)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Viral Vaccines (immunology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the aftermath of the SARS epidemic, there has been significant progress in understanding the molecular and cell biology of SARS-CoV. Some of the milestones are the availability of viral genome sequence, identification of the viral receptor, development of an infectious cDNA clone, and the identification of viral antigens that elicit neutralizing antibodies. However, there is still a large gap in our understanding of how SARS-CoV interacts with the host cell and the rapidly changing viral genome adds another variable to this equation. Now the SARS-CoV story has entered a new phase, a search for preventive strategies and a cure for the disease. This review highlights the progress made in identifying molecular aspects of SARS-CoV biology that is relevant in developing disease prevention strategies. Authors conclude that development of successful SARS-CoV vaccines and antivirals depends on the progress we make in these areas in the immediate future.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15833113</PMID><DateCompleted><Year>2006</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><PubDate><Year>2005</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol. J.</ISOAbbreviation></Journal><ArticleTitle>Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies.</ArticleTitle><Pagination><MedlinePgn>35</MedlinePgn></Pagination><Abstract><AbstractText>In the aftermath of the SARS epidemic, there has been significant progress in understanding the molecular and cell biology of SARS-CoV. Some of the milestones are the availability of viral genome sequence, identification of the viral receptor, development of an infectious cDNA clone, and the identification of viral antigens that elicit neutralizing antibodies. However, there is still a large gap in our understanding of how SARS-CoV interacts with the host cell and the rapidly changing viral genome adds another variable to this equation. Now the SARS-CoV story has entered a new phase, a search for preventive strategies and a cure for the disease. This review highlights the progress made in identifying molecular aspects of SARS-CoV biology that is relevant in developing disease prevention strategies. Authors conclude that development of successful SARS-CoV vaccines and antivirals depends on the progress we make in these areas in the immediate future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stark</LastName><ForeName>Caren J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, MD 20892, USA. starkc@cber.fda.gov</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atreya</LastName><ForeName>C D</ForeName><Initials>CD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>68</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>04</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>4</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>9</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>4</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15833113</ArticleId><ArticleId IdType="pii">1743-422X-2-35</ArticleId><ArticleId IdType="doi">10.1186/1743-422X-2-35</ArticleId><ArticleId IdType="pmc">PMC1087510</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Oct 10;302(5643):276-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12958366</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 2003 Nov;148(11):2207-35</Citation><ArticleIdList><ArticleId IdType="pubmed">14579179</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000</Citation><ArticleIdList><ArticleId IdType="pubmed">14569023</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2003 Nov 28;311(4):870-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14623261</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2003 Dec 15;31(24):7117-30</Citation><ArticleIdList><ArticleId IdType="pubmed">14654687</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2431-41</Citation><ArticleIdList><ArticleId IdType="pubmed">14681510</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41</Citation><ArticleIdList><ArticleId IdType="pubmed">14983044</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2004 Mar 12;303(5664):1666-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14752165</ArticleId></ArticleIdList></Reference><Reference><Citation>Respirology. 2003 Nov;8 Suppl:S25-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15018130</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):269-76</Citation><ArticleIdList><ArticleId IdType="pubmed">15030696</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Mar;10(3):489-93</Citation><ArticleIdList><ArticleId IdType="pubmed">15109419</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2004 Jul 9;319(4):1228-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15194498</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Apr;10(4):581-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15200845</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Jul;78(14):7311-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15220404</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Aug;78(15):7863-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15254158</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2004 Oct 1;327(2):169-74</Citation><ArticleIdList><ArticleId IdType="pubmed">15351204</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Microbiol. 2004 Aug;7(4):412-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15358261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12781533</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2003 Jun 13;113(6):701-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12809601</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Lung Res. 2000 Jan-Feb;26(1):13-26</Citation><ArticleIdList><ArticleId IdType="pubmed">10660833</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2000 Nov 1;165(9):5211-20</Citation><ArticleIdList><ArticleId IdType="pubmed">11046054</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2001 Jul;75(14):6450-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11413312</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Apr 19;326(7394):850-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12702616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2003 Jul 1;168(1):7-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12773318</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2003 Jul;200(3):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12845623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Jul 10;424(6945):121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12853923</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2003 Aug 15;308(1):148-51</Citation><ArticleIdList><ArticleId IdType="pubmed">12890493</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Jul 31;349(5):508-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12890855</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2003 Sep;84(Pt 9):2305-15</Citation><ArticleIdList><ArticleId IdType="pubmed">12917450</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2003 Aug;9(8):1635-45</Citation><ArticleIdList><ArticleId IdType="pubmed">12918094</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation><ArticleIdList><ArticleId IdType="pubmed">12927536</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2003 Oct;125(4):1011-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14517783</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Genet Evol. 2003 Sep;3(3):219-25</Citation><ArticleIdList><ArticleId IdType="pubmed">14522185</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2003 Dec;28(3):239-44</Citation><ArticleIdList><ArticleId IdType="pubmed">14522061</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2003 Oct 10;278(41):39578-82</Citation><ArticleIdList><ArticleId IdType="pubmed">12917423</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 2004 Oct;16(10):1423-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15314040</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Nov;78(22):12557-65</Citation><ArticleIdList><ArticleId IdType="pubmed">15507643</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Microbiol. 1997;51:151-78</Citation><ArticleIdList><ArticleId IdType="pubmed">9343347</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15530413</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Dec;78(24):14043-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15564512</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2005 Jan 5;331(1):128-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15582659</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2004 Dec 15;173(12):7602-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15585888</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2005 Jan;86(Pt 1):211-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15604448</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2005 Jan 15;191(2):193-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15609228</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2005;287:229-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15609514</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2005 Jan;3(1):e5</Citation><ArticleIdList><ArticleId IdType="pubmed">15630477</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):797-801</Citation><ArticleIdList><ArticleId IdType="pubmed">15642942</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Res. 2005;6:8</Citation><ArticleIdList><ArticleId IdType="pubmed">15661082</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2005 Feb;65(2):69-78</Citation><ArticleIdList><ArticleId IdType="pubmed">15708633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Mar;79(5):2678-88</Citation><ArticleIdList><ArticleId IdType="pubmed">15708987</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Chem Chemother. 2005;16(1):13-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15739618</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Biol (Basel). 2004;119:129-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15742624</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2005 Mar 30;334(1):74-82</Citation><ArticleIdList><ArticleId IdType="pubmed">15749124</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2005 Mar;11(3):446-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15757562</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Microbiol Biotechnol. 2005 Aug;68(2):220-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15660214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 3;361(9368):1519-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12737864</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 3;361(9368):1558</Citation><ArticleIdList><ArticleId IdType="pubmed">12737884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 10;361(9369):1615-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12747883</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1995-2005</Citation><ArticleIdList><ArticleId IdType="pubmed">12671061</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12671062</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002788 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002788 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:15833113
|texte= Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15833113" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |